Aim Bulletin
Schools to become focus for eEnergy amid Covid-19
Energy efficiency-as-a-service provider eEnergy Group updated the market on its third quarter of trading on Monday, as well as the effect of the Covid-19 coronavirus pandemic on its business, reporting that from 1 January to 3 April, it signed 48 new contracts, including 21 schools in the UK and Ireland.
Secure Income REIT still intending to pay quarterly dividend
Secure Income REIT updated the market on its operations in light of the Covid-19 coronavirus pandemic on Monday, saying that of the rents due to date, representing over 94% of the total quarterly rent roll, 76% had been paid on time.
OptiBiotix enters manufacturing deal with France's Laboratoire PYC
Life sciences company OptiBiotix Health has entered into a contract manufacturing agreement with Laboratoire PYC in France, it announced on Monday.
Ergomed joins Covid-19 therapy programme
Specialised pharmaceutical services provider Ergomed announced on Monday that it is providing support for a clinical development programme for ‘namilumab’, a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment of patients with rapidly worsening Covid-19 coronavirus symptoms.
Angling Direct warns on profits, withdraws guidance
Fishing equipment retailer Angling Direct issued a profit warning and withdrew market guidance on Monday, having shuttered its stores as a result of the Covid-19 pandemic.
Immedia results to be ‘significantly below’ expectations due to Covid-19
AIM-listed Immedia warned on Monday that 2020 results are likely to be "significantly below" any previous market expectations as it takes a hit from the coronavirus outbreak.
CentralNic 'resilient' in face of pandemic
Internet domain name and services company CentralNic Group updated the market in relation to the Covid-19 coronavirus pandemic on Monday, reporting that to date, it had not experienced interruptions in its services to customers or in its supply chain.
Avacta raises £3.75m, expects minimal impact from pandemic
Biotherapeutics company Avacta Group announced on Monday that, in response to “substantial” institutional interest, it has conditionally raised gross proceeds of £3. 75m under a placing, through the issue of 20,833,333 new ordinary shares at a price of 18p each.
Be Heard withdraws guidance, implements contingency plans
Digital marketing group Be Heard withdrew its full-year guidance on Monday and implemented a number of contingency plans as the Covid-19 pandemic continued to have a "material and adverse impact" on the demand and supply sides of both the domestic and foreign economies.